China Market Access After NRDL Maturity: What Comes After the Price Reset? Gaining inclusion in China’s National Reimbursement Drug List (NRDL) is no longer the final victory for Western pharmaceutical companies; it is just the beginning. Securing a spot on the list does not guarantee immediate hospital uptake, nor does it automatically eliminate patient affordability…
Creating a Single Source of Truth Across Six Systems with Continuous Data Movement Eliminate ID sprawl. Eliminate revenue risk. A global professional services firm faced severe identity fragmentation across tax, risk, finance, CRM, ERP, and document management systems due to conflicting identifier formats and structural data silos. This disconnect led to duplicate records, manual reconciliation…
The State of Loyalty on Shopify Plus How the world’s highest-volume Shopify merchants actually run loyalty: adoption, benchmarks by size and vertical, and 12 months of switching data nobody has published before. Ten things every Plus brand should know Unlock the findings inside: The full Plus leaderboard, ranked #1 to #9 The revenue band where adoption…
